HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.

Saved in:
Bibliographic Details
Title: HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.
Authors: Kogler M; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Tortola L; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria. josef.penninger@ubc.ca luigi.tortola@biol.ethz.ch.; Institute of Molecular Health Sciences, Department of Biology, ETH Zurich, Switzerland., Negri GL; Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada., Leopoldi A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., El-Naggar AM; Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.; Department of Pathology, Faculty of Medicine, Menoufia University, Menoufia Governorate, Egypt., Mereiter S; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Gomez-Diaz C; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Nitsch R; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria.; Advanced Medicines Safety, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Tortora D; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Kavirayani AM; Vienna BioCentre Core Facilities, Vienna BioCentre, Vienna, Austria., Gapp BV; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Rao S; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Uribesalgo I; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Hoffmann D; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Cikes D; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Novatchkova M; Research Institute of Molecular Pathology, Vienna BioCentre, Vienna, Austria., Williams DA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Trent JM; Translational Genomics Research Institute (TGen), Phoenix, Arizona., Ikeda F; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Hagelkruys A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria., Sorensen PH; Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada., Penninger JM; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCentre, Vienna, Austria. josef.penninger@ubc.ca luigi.tortola@biol.ethz.ch.; Department of Medical Genetics, Life Science Institute, University of British Columbia, Vancouver, British Columbia, Canada.
Source: Cancer research [Cancer Res] 2020 Jul 15; Vol. 80 (14), pp. 3009-3022. Date of Electronic Publication: 2020 May 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-19-2270